title: Prevalence of primary blepharospasm in Sardinia, Italy: a service-based survey.
abstract: We performed a service-based epidemiological study of primary blepharospasm in the island of Sardinia (Italy). Due to its favorable geographical location, we are confident we will provide reliable data from patients seeking botulinum toxin treatment. A total of 53 patients were assessed. Prevalence was estimated to be 32.2 per 1 million (95% confidence interval, 23.0-40.8). These results are in line with those obtained in other similar surveys, that is, record-based, and performed in various European regions such as Northern England, the Munich area, as well as the Epidemiologic Study of Dystonia in Europe.
authors.affiliation: Neurology Service and Stroke Unit, General Hospital S. Michele AOB G. Brotzu, Cagliari, Sardinia, Italy. giovannicossu@aob.it
authors.forename: Giovanni
authors.initials: G
authors.lastname: Cossu
authors.forename: Alessandra
authors.initials: A
authors.lastname: Mereu
authors.forename: Marcello
authors.initials: M
authors.lastname: Deriu
authors.forename: Maurizio
authors.initials: M
authors.lastname: Melis
authors.forename: Andrea
authors.initials: A
authors.lastname: Molari
authors.forename: Giannina
authors.initials: G
authors.lastname: Melis
authors.forename: Laura
authors.initials: L
authors.lastname: Minafra
authors.forename: Tiziana
authors.initials: T
authors.lastname: Pisano
authors.forename: Carlo
authors.initials: C
authors.lastname: Cianchetti
authors.forename: Enzo
authors.initials: E
authors.lastname: Ortu
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Sau
authors.forename: Isidoro
authors.initials: I
authors.lastname: Aiello
authors.forename: Miriana
authors.initials: M
authors.lastname: Fresu
authors.forename: Maria Giovanna
authors.initials: MG
authors.lastname: Marrosu
authors.forename: Paolo
authors.initials: P
authors.lastname: Contu
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001764:Blepharospasm / Q000188:drug therapy / Q000453:epidemiology*; D001905:Botulinum Toxins / Q000627:therapeutic use; D016001:Confidence Intervals; D003430:Cross-Sectional Studies; D003625:Data Collection; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012737:Sex Factors
chemical_list: D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins